22 October 2024 - Pivotal Phase 3 study shows significant improvement in progression-free survival with a favourable safety profile. ...
18 October 2024 - Zoryve foam represents the first topical treatment for seborrheic dermatitis with a new mechanism of action approved ...
17 October 2024 - Tyenne is the first and only tocilizumab biosimilar to be launched in Canada. ...
16 October 2024 - First and only treatment approved by Health Canada for repigmentation of non-segmental vitiligo. ...
16 October 2024 - Daybue is the first and only therapy approved in Canada for the treatment of Rett syndrome, a ...
4 October 2024 - Telix Pharmaceuticals today announces that Health Canada has approved the use of Illuccix (kit for the ...
30 September 2024 - Patient special access program continues during Health Canada review. ...
26 September 2024 - Vertex Pharmaceuticals today announced that Health Canada has accepted for review its new drug submission for ...
25 September 2024 - First regulatory authorisation of a CRISPR-based gene-editing therapy in Canada. ...
24 September 2024 - Omicron KP.2 variant adapted vaccine Comirnaty is now authorised in Canada for individuals 6 months of age ...
17 September 2024 - Spikevax is the first updated COVID-19 vaccine authorised in Canada for 2024-2025, offering a timely solution to ...
17 September 2024 - Health Canada has approved an updated version of Moderna’s COVID-19 vaccine, a decision that means some ...
18 September 2024 - To potentially include adolescents and antibody persistence up to two years. ...
17 September 2024 - If approved, omaveloxolone would be the only disease specific treatment option for patients living with this progressive ...
12 September 2024 - This is the ninth indication for Dupixent in Canada and its second in gastroenterology. ...